Protonix Granule, Delayed Release
Product Images NDC 0008-0844

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Protonix (NDC 0008-0844). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Wyeth Pharmaceuticals Llc, A Subsidiary Of Pfizer Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Protonix 01)

Chemical structure of pantoprazole sodium sesquihydrate showing the molecular arrangement including pyridine and benzimidazole rings with associated functional groups and sodium ion.*

FDA Label Image

Logo (Protonix 02)

FDA Label Image

Protonix 02a

FDA Label Image

Logo (Protonix 03)

FDA Label Image

Principal Display Panel (20 mg Tablet Bottle Label)

Label for Protonix delayed-release tablets, 20 mg strength, containing pantoprazole sodium as the active ingredient. The label states 'Swallow tablets whole. Do NOT split, chew, or crush tablets.' The package size is 90 tablets. It is a prescription oral tablet distributed by Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. The label includes the NDC 0008-0843-81 and storage instructions.*

FDA Label Image

Principal Display Panel (40 mg Tablet Bottle Label)

Label for Protonix Delayed-Release tablets showing the active ingredient pantoprazole sodium at 40 mg strength. Oral delayed-release tablet dosage form in a container of 90 tablets. The label includes usage instructions to swallow tablets whole and not to split, chew, or crush. Distributed by Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.*

FDA Label Image

Principal Display Panel (40 mg Granule Packet)

Label for Protonix 40 mg (pantoprazole sodium) delayed-release oral suspension packets. The label indicates it is for suspension in apple juice or applesauce only, with each packet containing 40 mg of pantoprazole. The product is labeled for Rx only and manufactured by Wyeth Pharmaceuticals LLC, a Pfizer subsidiary.*

FDA Label Image

Principal Display Panel (40 mg Granule Packet Carton)

Protonix 40 mg delayed-release oral suspension packets by Wyeth Pharmaceuticals LLC, a Pfizer subsidiary. The label shows pantoprazole sodium as the active ingredient, in 30 packets per package. Instructions note suspension with apple juice or applesauce only, with detailed patient administration directions. The product is made in France under license from Takeda GmbH.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.